BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34435898)

  • 1. Novel strategies for the fight of Alzheimer's disease targeting amyloid-β protein.
    Xie Y; Wang Y; Jiang S; Xiang X; Wang J; Ning L
    J Drug Target; 2022 Mar; 30(3):259-268. PubMed ID: 34435898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review.
    Jeremic D; Jiménez-Díaz L; Navarro-López JD
    Ageing Res Rev; 2021 Dec; 72():101496. PubMed ID: 34687956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Y
    Matrone C; Iannuzzi F; Annunziato L
    Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease.
    Uddin MS; Kabir MT; Rahman MS; Behl T; Jeandet P; Ashraf GM; Najda A; Bin-Jumah MN; El-Seedi HR; Abdel-Daim MM
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Products Targeting Amyloid Beta in Alzheimer's Disease.
    Lee JH; Ahn NH; Choi SB; Kwon Y; Yang SH
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease.
    Ghosh N; Kundu LM
    Future Med Chem; 2021 Oct; 13(20):1767-1794. PubMed ID: 34498978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
    Cho JE; Kim JR
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimicrobial protection hypothesis of Alzheimer's disease.
    Moir RD; Lathe R; Tanzi RE
    Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta.
    Rofo F; Buijs J; Falk R; Honek K; Lannfelt L; Lilja AM; Metzendorf NG; Gustavsson T; Sehlin D; Söderberg L; Hultqvist G
    Transl Neurodegener; 2021 Sep; 10(1):38. PubMed ID: 34579778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Imaging of Beta-Amyloid Plaques in Alzheimer's Disease.
    Luo Z; Xu H; Liu L; Ohulchanskyy TY; Qu J
    Biosensors (Basel); 2021 Jul; 11(8):. PubMed ID: 34436057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic Design of Amyloid-β Species Fluorescent Probes for Alzheimer's Disease.
    Su D; Diao W; Li J; Pan L; Zhang X; Wu X; Mao W
    ACS Chem Neurosci; 2022 Mar; 13(5):540-551. PubMed ID: 35132849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
    Conway KA; Baxter EW; Felsenstein KM; Reitz AB
    Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
    Lemere CA
    Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid Beta (Aβ) Peptide and Factors that Play Important Roles in Alzheimer's Disease.
    Jamasbi E; Wade JD; Separovic F; Hossain MA
    Curr Med Chem; 2016; 23(9):884-92. PubMed ID: 26923680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.